A 58-year-old man with a history of well-controlled diabetes mellitus (HbA1c 6.5%) came to the emergency department on March 12, with cough, dyspnea and fever of 3 days duration.
On physical examination, the patient developed fever (39 °C) and hypoxemia, with oxygen saturation of 90% in room air.
A flu test was negative.
A chest X-ray showed bilateral alveolar opacities.
The nasopharyngeal smear sent for a SARS-CoV-2 PCR test was positive.
The patient was admitted and treatment with ceftriaxone (1 g daily IV) was started.
( ) ,
hydroxychloroquine (initial dose 800 mg, then 400 mg daily).
On March 14th (day 5 of symptoms), his hypoxemia worsened despite the mask with reservoir, with a decrease in oxygen saturation to 70%.
C-reactive protein was 142 mg/L; ferritin, 2.188 ng/mL.
She was admitted to the ICU where she was intubated and mechanically▁ventilated.
The patient met the criteria for severe ARDS, with a partial pressure of arterial oxygen (PaO2) and a fraction of oxygen (FiO2) of 98.
The patient was treated with a protocol of daily placement in prone position.
On March 22, she had acute kidney injury (AKI), which required continuous renal replacement therapy (CRT).
A review of the medical history revealed no history of chronic nephropathy.
Due to the closure of the dialysis circuit, the patient was treated with continuous infusion of heparin, not administered.
On March 23, she presented bilateral pneumothorax that required thoracic drainage.
His condition worsened despite the measures taken.
The patient developed vasopressive therapy-resistant shock and died on March 26th.
